Nektar Therapeutics (NASDAQ: NKTR)’s Stock Market Position Could Improve In The Coming Months
In the last trading session, 4.72 million shares of the Nektar Therapeutics (NASDAQ:NKTR) were traded, and its beta was 0.74. Most recently the company’s share